Family Medicine Doctors in Divide, CO Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Gregory Unruh, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 34 Hybroook Road South, Divide, CO 80814 Phone: 719-632-5700 Fax: 719-687-4457 |
News Archive
Linagliptin mono- and combination therapy improves blood glucose control
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
New study compares effectiveness of tinzaparin and warfarin in patients with active cancer, recurrent VTE
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
Study: Young adults who are obese can expect to lose up to 10 years in life expectancy
Young adults classified as obese in Australia can expect to lose up to 10 years in life expectancy, according to a major new study.
Mayo Clinic's programs offer hope and treatment to tobacco-dependent patients
Mayo Clinic's Nicotine Dependence Center (NDC) in Rochester is celebrating its 25th anniversary this year. As one of the first centers in the country to focus exclusively on treatments for tobacco dependence when it opened in 1988, the NDC has been at the forefront of the battle of nicotine addiction nationally as well as globally, offering the latest education and training programs, advancing research aimed at tobacco dependence interventions and offering treatment approaches to tobacco users.
MDS intends to make Substantial Issuer Bid
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company intends to make a Substantial Issuer Bid (the "offer"), pursuant to which the Company will offer to repurchase for cancellation up to between 40% and 46% of its outstanding Common Shares for an aggregate purchase price of up to US$450 million.
› Verified 7 days ago